0.0360
+0.0070
+(24.14%)
At close: 4:10:17 PM GMT+10
Breakdown
TTM
6/30/2023
6/30/2022
6/30/2021
6/30/2020
Total Revenue
--
618.5680
99.7300
--
--
Gross Profit
--
618.5680
99.7300
--
--
Operating Expense
5,301.3160
10,210.1260
14,212.2570
12,666.8490
8,004.8560
Operating Income
-5,046.2240
-9,591.5580
-14,112.5270
-12,666.8490
-8,004.8560
Net Non Operating Interest Income Expense
-169.4270
-313.2790
-78.2060
7.0490
60.5800
Other Income Expense
971.2510
2,774.5730
4,106.7220
4,191.7540
2,665.4730
Pretax Income
-4,318.8330
-7,130.2640
-10,084.0110
-8,468.0460
-5,278.8030
Net Income Common Stockholders
-4,318.8330
-7,130.2640
-10,084.0110
-8,468.0460
-5,278.8030
Basic EPS
-0.04
-0.09
-0.14
-0.14
-0.12
Diluted EPS
-0.04
-0.09
-0.14
-0.14
-0.12
Basic Average Shares
130,273.0860
78,757.4820
71,078.2250
59,053.5170
42,506.6350
Diluted Average Shares
130,273.0860
78,757.4820
71,078.2250
59,053.5170
42,506.6350
Net Income from Continuing & Discontinued Operation
-4,318.8330
-7,130.2640
-10,084.0110
-8,468.0460
-5,278.8030
Normalized Income
-4,361.1530
-7,130.2640
-10,084.0110
-8,468.0460
-5,278.8030
Interest Income
23.3600
17.9460
3.0190
7.0490
60.5800
Interest Expense
--
331.2250
81.2250
--
--
Net Interest Income
-169.4270
-313.2790
-78.2060
7.0490
60.5800
EBIT
-2,253.7050
-6,799.0390
-10,002.7860
-12,666.8490
-8,004.8560
EBITDA
-626.7020
-5,097.6030
-8,274.3580
-11,660.4730
-7,622.4340
Reconciled Depreciation
1,627.0030
1,701.4360
1,728.4280
1,006.3760
382.4220
Net Income from Continuing Operation Net Minority Interest
-4,318.8330
-7,130.2640
-10,084.0110
-8,468.0460
-5,278.8030
Total Unusual Items Excluding Goodwill
42.3200
--
--
--
--
Total Unusual Items
42.3200
--
--
--
--
Normalized EBITDA
-669.0220
-5,097.6030
-8,274.3580
-11,660.4730
-7,622.4340
6/30/2020 - 12/17/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RAC.AX Race Oncology Limited
1.0200
-0.97%
AVE.AX Avecho Biotechnology Limited
0.0050
0.00%
ILA.AX Island Pharmaceuticals Limited
0.1700
-2.86%
AGN.AX Argenica Therapeutics Limited
0.7250
+8.21%
RAD.AX Radiopharm Theranostics Limited
0.0230
+9.52%
BTC.AX BTC Health Limited
0.0500
0.00%
EZZ.AX EZZ Life Science Holdings Limited
1.4600
+10.61%
NSB.AX NeuroScientific Biopharmaceuticals Limited
0.0350
0.00%
IXC.AX Invex Therapeutics Ltd
0.0700
0.00%
RNV.AX RENERVE FPO [RNV]
0.1100
-4.35%